Clinical trial
Safety, Efficacy and Pharmacokinetics of an Antifungal in Patients Undergoing…
NCT00413439 · Basilea Pharmaceutica, Industry · Completed
Key facts
| NCT number | NCT00413439 |
|---|---|
| Title | Safety, Efficacy and Pharmacokinetics of an Antifungal in Patients Undergoing Chemotherapy |
| Official title | Open Label, Multi-center, Sequential Group Clinical Study to Determine the Safety and Efficacy of Escalating Dosing Regimens of Intravenous BAL8557 in the Prophylaxis of Patients Undergoing Chemotherapy for Acute Myeloid Leukemia |
| Lead sponsor | Basilea Pharmaceutica, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Acute Myeloid Leukemia |
| Intervention type | Drug |
| Interventions | Isavuconazole |
| Enrollment | 18 |
| Start date | May 1, 2006 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Dec 19, 2006 |
| Last update posted | May 10, 2023 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: